Teva sees higher margins, lower debt from restructuring | Financial Times
Teva Pharmaceuticals Names Kare Schultz As New CEO | Fortune
Teva chief leaves as drugmaker struggles to take its medicine | Financial Times
Teva CEO Erez Vigodman Steps Down | CHEManager
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Jill Stafford - Associated Director Lab Systems Global IT - Teva Pharmaceuticals | LinkedIn
Teva Pharmaceutical Is in Recovery - WSJ
Teva CEO Vigodman steps down as drugmaker seeks direction | The Times of Israel
Former Teva generics chief Olafsson steps into CEO seat at growth-challenged Hikma | FiercePharma
Former Teva CEO Eli Hurvitz tours the new Teva Pharmaceutical... News Photo - Getty Images
Teva Pharmaceuticals CEO Talks "Trough Year", 2020 Turnaround
Teva Pharmaceuticals - Wikipedia
:quality(90)/images.vogel.de/vogelonline/bdb/1286400/1286421/original.jpg "Kåre Schultz is Named New President & CEO of Teva Pharmaceutical")
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Kåre Schultz, CEO of Teva Pharmaceuticals, makes an opening statement remotely during a House Committee on Oversight and Reform Committee hearing to discuss unsustainable drug prices with CEO's of major drug companies
Teva Pharmaceuticals Sees Small Rise in Stock After Announcing New CEO
Teva Pharmaceuticals CEO Kare Schultz testifies by video conference during a hearing before the US House of Representatives Committee on Oversight and Reform focused on the cost of prescription drugs, in the
Teva Pharmaceuticals - Wikipedia
Teva Pharmaceuticals on Twitter: "Speaking at #JPM2020, Teva CEO Kåre Schultz discussed the company's restructuring, future growth drivers, and a focus on the needs of patients and customers. Listen to a replay
New Teva CEO reorganizes with an 'ax, not hedge clippers or pruning shears' - STAT
1,487 Teva Photos and Premium High Res Pictures - Getty Images
